tender for procurement of anticancer drugs for the year 2026-27 , abiraterone acetate tab ip 250 mg , afatinib tab 30 mg , bendamustine inj ip 100 mg , bortezomib inj ip 2 mg , capecitabine tab ip 500 mg , cytarabine inj ip/bp 100 mg , etoposide cap ip 50 mg , etoposide inj ip 100 mg , exemestane tab ip 25 mg , ferric carboxymaltose inj 1 gm/20 ml , filgrastim inj ip 300 mcg , fulvestrant inj 250 mg , gefitinib tab ip 250 mg , l.asparaginase inj 5000 iu , lapatinib tab ip 250 mg , letrozole tab ip/usp 2.5 mg , paclitaxel nanoparticle inj 100 mg , pazopanib tab 400 mg , pegfilgrastim inj 6 mg , sunitinib cap 12.5 mg , bevacizumab inj 100 mg , bevacizumab inj 400 mg , carboplatin inj ip 150 mg , carboplatin inj ip 450 mg , cisplatin inj ip 10 mg , cisplatin inj ip 50 mg , dasatinib tab 20 mg , dasatinib tab 50 mg , docetaxel inj ip 20 mg , docetaxel inj ip 80 mg , docetaxel inj ip 120 mg , doxorubicin inj (lyophilised) ip 10 mg , doxorubicin inj (lyophilised) ip 50 mg , epirubicin inj ip 10 mg , epirubicin inj ip 50 mg , erlotinib tab ip 100 mg , erlotinib tab ip 150 mg , gemcitabine inj ip 200 mg , gemcitabine inj ip 1 gm , ifosfamide with mesna inj 1 gm , ifosfamide with mesna inj 2 gm , imatinib tab ip 100 mg , imatinib tab ip 400 mg , irinotecan inj ip 40 mg , irinotecan inj ip 100 mg , lenalidomide cap 10 mg , lenalidomide cap 5mg , leuprolide acetate inj 3.75 mg , leuprolide acetate inj 11.25 mg , leuprolide acetate inj 22.5 mg , methotrexate inj ip 50 mg , methotrexate inj ip 500 mg , nilotinib cap 200 mg , nilotinib cap 150 mg , oxaliplatin inj ip 50 mg , oxaliplatin inj ip 100 mg , paclitaxel inj ip 30 mg , paclitaxel inj ip with codon set 100 mg , paclitaxel inj ip with codon set 260 mg , pemetrexed inj ip 100 mg , pemetrexed inj ip 500 mg , rituximab inj 100 mg , rituximab inj 500 mg , temozolomide cap ip 100 mg , temozolomide cap ip 250 mg , trastuzumab inj 150 mg , trastuzumab inj 440 mg